Redhill Biopharma RDHL
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.03 | 4 | 25 | |||
| 2025Q2 | 1.94 | -4 | 18 | |||
| 2024Q4 | 6.21 | -5 | 18 | |||
| 2024Q2 | 9.27 | 0 | 22 | |||
| 2023Q2 | 30 | 3 | 27.8 | 1 | 1.62 | 35 |
| 2023Q1 | 102.25 | 2 | 50 | 46.16 | 59 | |
| 2022Q4 | 140.3 | -48 | -4 | -2.36 | 159 | |
| 2022Q3 | 502.5 | -46 | -36 | -21.96 | 157 | |
| 2022Q2 | 870 | -12 | -12 | -6.99 | 168 | |
| 2022Q1 | 2520 | -5 | -17 | -9.84 | 167 | |
| 2021Q4 | 2580 | 9 | -238.67 | -24 | -13.26 | 181 |
| 2021Q3 | 4580 | 12 | -104 | -21 | -10.97 | 186 |
| 2021Q2 | 6880 | 30 | -70.49 | -29 | -13.74 | 204 |
| 2021Q1 | 7320 | 53 | -68.34 | -23 | -11.42 | 220 |
| 2020Q4 | 8080 | 14 | -114.2 | -24 | -13.93 | 180 |
| 2020Q3 | 10220 | 29 | -58.86 | -19 | -11.12 | 169 |
| 2020Q2 | 6700 | 35 | -16 | 166 | ||
| 2012Q4 | 19 | -3 | 20 |